Vai al contenuto

Interazioni tra farmaci

Baricitinib + Upadacitinib

Gravità: Controindicata

Baricitinib and Upadacitinib: contraindicated interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Baricitinib and upadacitinib are both JAK inhibitors, so using them together duplicates therapy without proven benefit. Exposure to JAK-related adverse effects such as serious infection, thrombosis, cytopenias and lipid rise is doubled.

Cosa significa questa interazione in parole semplici

Baricitinib and Upadacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Baricitinib belongs to Musculoskeletal; Upadacitinib belongs to Musculoskeletal.

Livello di evidenza: High

Perché avviene

Therapeutic duplication of JAK inhibition

Cosa fare

Do not combine; if switching between JAK inhibitors, stop the first agent before starting the second.

Cosa chiedere al farmacista

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Baricitinib e Upadacitinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Baricitinib with Upadacitinib?

MediHelp rates the interaction as contraindicated. Baricitinib and Upadacitinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Baricitinib and upadacitinib are both JAK inhibitors, so using them together duplicates therapy without proven benefit. Exposure to JAK-related adverse effects such as serious infection, thrombosis, cytopenias and lipid rise is doubled.

How serious is the interaction between Baricitinib and Upadacitinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not combine; if switching between JAK inhibitors, stop the first agent before starting the second.

What other medicines interact with Baricitinib?

MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi